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Abstract. 
 
A single unattached kinetochore can delay 
anaphase onset in mitotic tissue culture cells (Rieder, 
C.L., A. Schultz, R. Cole, G. Sluder. 1994. 
 
J. Cell Biol.
 
 
127:1301–1310). Kinetochores in vertebrate cells con-
tain multiple binding sites, and tension is generated at 
kinetochores after attachment to the plus ends of spin-
dle microtubules. Checkpoint component Mad2 local-
izes selectively to unattached kinetochores (Chen, R.-H., 
J.C. Waters, E.D. Salmon, and A.W. Murray. 1996. 
 
Sci-
ence.
 
 274:242–246; Li, Y., and R. Benezra. 
 
Science.
 
 274:
246–248) and disappears from kinetochores by late 
metaphase, when chromosomes are properly attached 
to the spindle. Here we show that Mad2 is lost from 
PtK
 
1
 
 cell kinetochores as they accumulate microtubules 
and re-binds previously attached kinetochores after mi-
crotubules are depolymerized with nocodazole. We 
also show that when kinetochore microtubules in 
metaphase cells are stabilized with taxol, tension at ki-
netochores is lost. The phosphoepitope 3f3/2, which has 
been shown to become dephosphorylated in response 
to tension at the kinetochore (Nicklas, R.B., S.C. Ward, 
and G.J. Gorbsky. 1995. 
 
J. Cell Biol.
 
 130:929–939), is 
phosphorylated on all 22 kinetochores after tension is 
reduced with taxol. In contrast, Mad2 only localized to an 
average of 2.6 out of the 22 kinetochores in taxol-treated 
PtK
 
1 
 
cells. Therefore, loss of tension at kinetochores 
occupied by microtubules is insufficient to induce Mad2 
to accumulate on kinetochores, whereas unattached ki-
netochores consistently bind Mad2. We also found that 
microinjecting antibodies against Mad2 caused cells ar-
rested with taxol to exit mitosis after 
 
z
 
12 min, while 
uninjected cells remained in mitosis for at least 6 h, 
demonstrating that Mad2 is necessary for maintenance 
of the taxol-induced mitotic arrest. We conclude that 
kinetochore microtubule attachment stops the Mad2 
interactions at kinetochores which are important for in-
hibiting anaphase onset.
 
K
 
inetochore
 
 attachment to microtubules provides
the essential link between chromosomes and the
spindle upon which they are segregated (Rieder
and Salmon, 1994). During the initial stages of chromo-
some attachment to the spindle in vertebrate tissue culture
cells, a kinetochore on a chromosome captures microtu-
bules from one spindle pole. When the opposing sister ki-
netochore captures microtubules from the other spindle
pole, the chromosome congresses to the spindle equator.
In anaphase, forces generated at kinetochores and along
kinetochore microtubules (i.e., microtubules attached to
the kinetochore) move the attached chromatids poleward
(Mitchison and Salmon, 1992). Therefore, accurate chro-
mosome segregation requires the proper attachment of ki-
netochores to the spindle before anaphase begins.
To ensure that chromosomes properly attach to the
spindle before anaphase onset, unattached kinetochores in
mitotic vertebrate tissue culture cells release an inhibitory
signal that delays anaphase until they properly attach to
the spindle (Rieder et al., 1994, 1995; for review see Nick-
las, 1997). Microtubule depolymerization (Brues and Co-
hen, 1936) or detachment of chromosomes from the spin-
dle with a microneedle (Li and Nicklas, 1995) also arrests
cells before anaphase, allowing time for the problem to be
corrected. This mitotic cell cycle checkpoint has been
given a number of names including “spindle assembly”
(Rudner and Murray, 1996), “kinetochore attachment”
(Rieder et al., 1994), “chromosome distribution” (Nicklas,
1997), and simply “mitotic” (Li and Benezra, 1996). We
use the term “spindle checkpoint” because it is clear and
avoids assumptions about which elements are being moni-
tored. It is an important checkpoint because it prevents
cells from entering anaphase under conditions that are
likely to result in missegregation and aneuploidy.
Genes that encode proteins involved in signaling of the
spindle checkpoint were first isolated from the budding
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yeast, 
 
Saccharomyces cerevisiae
 
. Mutations in Mad1, Mad2,
Mad3 (mitotic arrest deficient; Li and Murray, 1991),
Bub1, Bub2, and Bub3 (budding uninhibited by benomyl;
Hoyt et al., 1991) all result in failure of cells to arrest in mi-
tosis after treatment with the microtubule-depolymerizing
drug benomyl.
Several studies suggest that the yeast Mad and Bub pro-
teins monitor kinetochore attachment to the spindle, as
opposed to spindle integrity. Cells with mutations in the
kinetochore component Ctf13 arrest in mitosis. This arrest
is dependent on the MAD1, MAD2, MAD3, BUB1, and
BUB3 gene products; the mitotic arrest induced by muta-
tions in CTF13 is eluded by mutations in these genes
(Wang and Burke, 1995). Therefore, defects in kineto-
chore components can delay anaphase onset via the spin-
dle checkpoint pathway. Another set of experiments im-
plicates kinetochore involvement in the yeast spindle
checkpoint. Yeast cells with multiple copies of short linear
or circular mini-chromosomes show pronounced mitotic
delays. These delays are abolished by mutations in the
spindle checkpoint genes or removal of the centromere
from the mini-chromosomes, demonstrating that the delay
is both checkpoint- and kinetochore-dependent (Wells
and Murray, 1996). In addition, the presence of partially
functional mutant centromeres (Spencer and Hieter, 1992)
has been shown to induce mitotic delays in yeast.
Genes encoding proteins homologous to Mad2 and
Bub1 have been cloned from vertebrates. The 
 
Xenopus
 
(Chen et al., 1996) and human (Li and Benezra, 1996) ho-
mologues of Mad2 (Xmad2 and hsMad2, respectively) and
the murine homologue of Bub1 (Taylor and McKeon,
1997) have all been shown to be critical for cell cycle arrest
in response to microtubule-depolymerizing drugs. Consis-
tent with the idea that these proteins monitor kinetochore
attachment to the spindle, each of the vertebrate homo-
logues localize to unattached kinetochores. Immunolocal-
ization to kinetochores is lost after chromosomes become
properly attached to the spindle at metaphase. Overex-
pression of the kinetochore-binding domain of the murine
homologue of Bub1 results in premature anaphase onset,
presumably by competing endogenous Bub1 off of kineto-
chores (Taylor and McKeon, 1997). These data suggest
that interaction of the spindle checkpoint components
with unattached kinetochores may signal inhibition of
anaphase onset.
How does the cell know if a kinetochore is properly at-
tached to the spindle? It is not understood which aspect of
kinetochore attachment to the mitotic spindle is moni-
tored by the spindle checkpoint. One possibility is that the
checkpoint components monitor microtubule binding to
kinetochores (Rieder et al., 1995). Alternatively, some evi-
dence suggests that the checkpoint monitors tension at ki-
netochores, as first proposed by McIntosh (1991). At-
tached kinetochores are subject to net poleward pulling
forces that place them under tension (Waters et al.,
1996
 
a
 
). Experimentally introduced tension at kinetochores
has been shown abolish the delay that normally occurs in
the presence of mal-oriented chromosomes (Li and Nick-
las, 1995). In addition, phosphorylation of a protein recog-
nized by the antibody 3f3/2 has been shown to be involved
in the spindle checkpoint (Campbell and Gorbsky, 1995)
and is regulated by tension (Nicklas et al., 1995).
We are interested in whether the spindle checkpoint
monitors tension at kinetochores, microtubule attachment
to kinetochores, or both. To attempt to differentiate be-
tween these possibilities, we used the localization of Mad2
to kinetochores as a marker for those kinetochores that
have not yet satisfied the checkpoint. Specifically, we
asked if Mad2 binds to kinetochores that are attached to
microtubules, but not under tension. McEwen et al. (1997)
have shown that treatment with the anti-cancer drug taxol
does not significantly decrease the average number of mi-
crotubules bound to kinetochores in metaphase PtK
 
1
 
 cells.
We show that taxol treatment did, however, reduce ten-
sion at kinetochores in metaphase PtK
 
1
 
 cells. We also used
immunofluorescence and digital imaging techniques to show
that decreasing tension at kinetochores, without detaching
them from the spindle, was not sufficient to induce Mad2
binding to kinetochores. In addition, we are interested in
the mechanism by which taxol inhibits cell proliferation.
We microinjected antibodies to Mad2 into taxol-treated
tissue culture cells and found that Mad2 was necessary for
maintenance of the taxol-induced mitotic arrest.
 
Materials and Methods
 
Cell Culture and Drug Treatment
 
PtK
 
1
 
 cells (American Type Culture Collection, Rockville, MD) were
maintained in MEM (Sigma Chemical Co., St. Louis, MO) containing
10% FBS, antibiotics, and antimycotics in a 37
 
8
 
C, 5% CO
 
2
 
 incubator. For
experiments in which cells were treated with taxol, 10 mM taxol in DMSO
stock (Sigma Chemical Co.) was diluted into media for a final concentra-
tion of 10 
 
m
 
M. For experiments in which cells were treated with nocoda-
zole, 10 mg/ml nocodazole in DMSO stock (Sigma Chemical Co.) was di-
luted into media for a final concentration of 20 
 
m
 
g/ml. Standard media was
then replaced with media containing the drug of choice.
 
Antibody Production and Purification
 
Full-length XMad2 tagged with six histidines at the NH
 
2
 
 terminus (Chen
et al., 1996) was expressed in 
 
Escherichia coli
 
 with Qiaexpress vector
pQE10 (Qiagen Inc., Chatsworth, CA). The expressed protein was puri-
fied according to Qiagen’s instructions for soluble proteins. Purified re-
combinant XMad2 dialyzed against PBS was used to immunize rabbits
(BAbCo, Richmond, CA). Polyclonal antibodies were purified on an
XMad2 affinity column prepared by binding the recombinant protein to
CH-activated Sepharose 4B (Pharmacia Biotech Inc., Piscataway, NJ; Wa-
terman-Storer and Holzbaur, 1996). Antibodies were eluted from the col-
umn with 100 mM triethylamine, and quickly transferred into injection
buffer (IB; 50 mM K-glutamate, 0.5 mM MgCl
 
2
 
) by gel filtration over a
NAP-10 column. Antibodies were concentrated using Microcon 10 micro-
concentrators (Amicon Corp., Danvers, MA). Affinity-purified antibodies
were used for all experiments described. Antibodies for microinjection
were stored in IB at a concentration of 0.4 mg/ml at 4
 
8
 
C. Antibodies used
for immunofluorescence and Western blots were stored at a concentration
of 0.2 mg/ml in IB containing 50% glycerol, 0.05% sodium azide, and 1%
BSA at 
 
2
 
20
 
8
 
C.
To analyze the immunoreactivity of the affinity-purified antibodies, to-
tal PtK
 
1
 
 cells were homogenized into SDS sample buffer, run on an SDS
12% polyacrylamide gel, and then electroblotted onto Immobilon-P (Mil-
lipore Corp., Bedford, MA) for Western blot analysis. Blots were first
stained with Coomassie to visualize total protein, then destained and
blocked with 5% dry milk in TBS with 0.05% Tween 20 for at least 1 h.
Blots were incubated in primary antibodies diluted 1:1000–1:10,000 for 1 h
at room temperature, rinsed, and then probed with donkey anti–rabbit
secondary antibodies conjugated to alkaline phosphatase (Jackson Immu-
noResearch, West Grove, PA). Blots were developed using Nitroblue tet-
razolium chloride and BCIP AP Color Development Reagents, according
to the manufacturer’s directions (Bio-Rad Laboratories, Hercules, CA). 
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Immunofluorescence and Microtubule 
Depolymerization in Lysed Cells
 
For immunofluorescence labeling, cells were first lysed in 0.5% Triton X-100
in PHEM (60 mM Pipes, 25 mM Hepes, 10 mM EGTA, and 4 mM
MgSO
 
4
 
) for 5 min. When preservation of the 3f3/2 phosphoepitope was
desired, 100 nM microcystin (Sigma Chemical Co.) was added to the lysis
buffer. Cells were then fixed in 1% formaldehyde (prepared fresh daily
from paraformaldehyde) for 20 min. For microtubule labeling, 0.1% glutar-
aldehyde was added to the 1% formaldehyde. Next, cells were rinsed in
PBST (PBS with 0.05% Tween 20) and subsequently blocked in 5% don-
key serum in PBS for at least 1 h. Cells were incubated for 45 min in pri-
mary antibodies diluted 1:50 into 5% donkey serum in PBS, rinsed, and
then incubated for 30–45 min in secondary donkey anti–rabbit, anti–
mouse, or anti–human antibodies, conjugated to either FITC or LSRC
(Jackson ImmunoResearch), diluted 1:50 in 5% donkey serum in PBS.
For double antibody labeling, cells were treated in the following order: (
 
1
 
)
block, (
 
2
 
) anti-XMad2 antibodies, (
 
3
 
) anti–rabbit secondary antibodies,
(
 
4
 
) block, (
 
5
 
) primary No. 2, and (
 
6
 
) secondary No. 2. For chromosome la-
beling, cells were treated with 20 
 
m
 
g/ml Hoechst 33342 in PBS for 30 s. All
incubations were performed at room temperature. CREST serum was a
gift from Drs. A. Desai and T.J. Mitchison (Harvard Medical School,
Cambridge, MA). 3f3/2 mAbs were a gift from Dr. G.J. Gorbsky (Univer-
sity of Virginia, Charlottesville, VA). DMA-1 mAbs to 
 
a
 
-tubulin were
purchased from Sigma Chemical Co. Cells were mounted for viewing in
50% glycerol, 50% PBS with 
 
N
 
-propyl gallate.
For experiments in which microtubules were depolymerized after cell
lysis, cells were first lysed with 5% Triton X-100 in PHEM containing 2 mM
ATP. Cells were then rinsed for 15 min in PHEM, replacing the buffer ev-
ery 5 min. To induce microtubule depolymerization, lysed cells were incu-
bated in buffer containing a high concentration of calcium (60 mM Pipes,
25 mM Hepes, 4 mM MgCl
 
2
 
, 4 mM CaCl
 
2
 
) for 2 h at 4
 
8
 
C. Cells were then
fixed and immunolabeled as described above.
Z-series optical sections of immunofluorescently labeled cells were ob-
tained using a multi-mode digital imaging system as previously described
(Waters et al., 1996
 
a
 
).
 
Microinjection
 
Cells grown on coverslips were mounted in modified Rose chambers, in
which a layer of mineral oil was used instead of a top coverslip. For both
microinjection and filming, cells were sustained with Hepes-buffered L-15
media containing antibiotics, antimycotics, and 10% FBS. Affinity-puri-
fied anti-XMad2 antibodies at a concentration of 0.4 mg/ml in IB were mi-
croinjected into mitotic PtK
 
1
 
 cells, as described by Mitchison and Salmon
(1992). Images were captured with a Hamamatsu C2400 CCD camera and
Argus 20 image processor (Hamamatsu Photonics, Bridgewater, NJ) and
recorded with a Panasonic S-VHS video recorder. A Sage air curtain incu-
bator was used to maintain the cells at 32
 
8
 
–34
 
8
 
C during microinjection and
filming. The following control injections were performed: (
 
a
 
) buffer that
flowed through the Microcon during antibody concentration, (
 
b
 
) antibod-
ies incubated with recombinant XMad2 (1:2 molar ratio) for 1 h at room
temperature, and (
 
c
 
) antibodies diluted with buffer, instead of recombi-
nant XMad2, and incubated for 1 h at room temperature.
 
Image Processing and Figure Production
 
12-bit digital images collected using Metamorph imaging software were
converted to 8-bit (Universal Imaging Corp., Westchester, PA). Images
were then transferred into Photoshop 3.0 (Adobe Microsystems, Moun-
tain View, CA), where they were sized, contrast-enhanced, pseudocol-
ored, and/or overlaid. Final images were montaged and labeled using
Claris Draw (Claris Corp., Santa Clara, CA).
 
Results
 
Affinity-purified Polyclonal Antibodies to Mad2 
Recognize One 24-kD Band
 
To determine the immunoreactivity of our polyclonal af-
finity-purified antibody, which was generated to recombi-
nant XMad2, we performed Western blot analysis of
whole PtK
 
1
 
 cells (Fig. 1, 
 
left lane
 
). We found that the anti-
body recognized one band of similar molecular weight to
XMad2 (24 kD; Fig. 1, 
 
middle lane
 
). Antibody that was in-
cubated with the recombinant XMad2 protein before use
showed no detectable immunoreactivity (Fig. 1, 
 
right lane
 
).
 
Mad2 Is Depleted from Attached Kinetochores
 
Antibodies to Mad2 localize to unattached kinetochores in
 
Xenopus
 
, newt (Chen et al., 1996), human (Li and Ben-
ezra, 1996), and PtK
 
1
 
 cells (Fig. 2; and see Fig. 4, 
 
A–D
 
).
Mad2 does not immunolocalize to attached kinetochores
in late metaphase and anaphase cells (see Fig. 4, 
 
E
 
 and 
 
F
 
;
Chen et al., 1996; Li and Benezra, 1996). Consistent with
observations in 
 
Xenopus
 
, newt, (Chen et al., 1996), and
human cells (Li and Benezra, 1996), we have found that
treatment with the microtubule–depolymerizing drug no-
codazole at concentrations that depolymerize all kinetochore
microtubules (Cassimeris et al., 1990) results in Mad2 lo-
calization to each of the 22 kinetochores in mitotic PtK
 
1
 
cells (
 
n
 
 5 
 
20; Fig. 2). These observations could mean that
either (
 
a
 
) Mad2 leaves kinetochores after microtubule at-
tachment and re-binds to kinetochores after microtubule
depolymerization, or (
 
b
 
) the epitope recognized by the an-
tibody is blocked when microtubules are bound to kineto-
chores, and then re-exposed after microtubule depolymer-
ization. We reasoned that we could differentiate between
these two possible explanations by removing the cytoplas-
mic Mad2 before microtubule depolymerization, so that
Mad2 would be unavailable to re-bind to the kinetochores
after microtubule depolymerization. We first lysed and
rinsed PtK
 
1
 
 cells to remove soluble Mad2 from the cyto-
plasm. We then incubated the lysed cells in a buffer con-
taining 4 mM calcium at 4
 
8
 
C for 2 h. Cells labeled for anti-
tubulin immunofluorescence revealed that this treatment
resulted in depolymerization of all microtubules (data not
shown). Cells were also immunolabeled with antibodies to
Mad2 (Fig. 3 
 
C
 
) and with CREST serum to visualize kine-
tochores (Fig. 3 
 
B
 
). We found that Mad2 was present on
kinetochores that were unattached before treatment, dem-
Figure 1. Affinity-purified anti-
XMad2 antibodies recognize
one 24-kD band in PtK1 cells.
Immunoblot analysis with the
affinity-purified anti-XMad2
polyclonal antibodies. Left, mid-
dle, right lanes, whole PtK1 cell;
left lane, Coomassie blue–stained
Immobilon; middle lane, immu-
noblot with anti-XMad2 anti-
bodies; right lane, immunoblot
with anti-XMad2 antibodies that
were pre-incubated with recom-
binant XMad2. Position of mo-
lecular weight markers are indi-
cated on left. 
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onstrating that this procedure does not remove insoluble
Mad2 from kinetochores (Fig. 3 
 
C
 
, 
 
bottom arrow
 
). How-
ever, we found no detectable Mad2 at previously attached
kinetochores after this procedure (Fig. 3 
 
C
 
, top arrow),
demonstrating that Mad2 is substantially depleted from at-
tached kinetochores. We found the same to be true for
cells treated with 10 
 
m
 
M taxol for 45 min before cell lysis
and microtubule depolymerization (data not shown).
 
Mad2 Leaves Attached Kinetochores As They 
Accumulate Microtubules
 
The kinetochores in mitotic PtK
 
1
 
 cells contain multiple mi-
crotubule binding sites (Brinkley and Cartwright, 1971).
After their initial attachment to the spindle, kinetochores
accumulate microtubules that form a bundle of microtu-
bules known as a kinetochore fiber (McEwen et al., 1997).
To better understand the relationship of Mad2 loss from
kinetochores to kinetochore fiber formation, we triple-
labeled mitotic PtK
 
1
 
 cells with antibodies to Mad2, anti-
bodies to 
 
a
 
-tubulin, and the DNA intercalating dye Hoechst
33342. Digital images were collected for each label, then
overlaid and pseudocolored (Fig. 4).
Mad2 localizes to the nuclear envelope, but not kineto-
chores, during interphase and prophase (data not shown;
Chen et al., 1996; Li and Benezra, 1996). We found that
Mad2 began accumulating on PtK
 
1
 
 cell kinetochores (Fig.
4 
 
A
 
, 
 
white arrows
 
) immediately after nuclear envelope
breakdown, even while some residual nuclear envelope–
associated Mad2 was still detectable along the chromo-
some arms (Fig. 4 
 
A
 
, 
 
white arrowhead
 
). In prometaphase,
Mad2 antibodies labeled unattached kinetochores brightly
(Fig. 4, 
 
C
 
 and 
 
D
 
, 
 
white arrows
 
). The attached kinetochore
on a mono-oriented chromosome was labeled weakly or
not at all (Fig. 4 
 
D
 
,
 
 red arrow
 
), whereas the unattached ki-
netochore that faced away from the spindle pole was
brightly labeled (Fig. 4, 
 
C
 
 and 
 
D
 
,
 
 white arrows
 
). On chro-
mosomes that had become bi-oriented and were congress-
ing to the spindle equator, the newly attached leading ki-
netochores (Fig. 4 
 
B
 
, 
 
yellow arrows
 
) labeled with Mad2
more brightly than the trailing kinetochores (Fig. 4 
 
B
 
, 
 
pur-
ple arrows
 
). Leading kinetochores also had less-pronounced
kinetochore fibers than trailing kinetochores (Fig. 4 
 
B
 
).
Attached kinetochores on bi-oriented chromosomes at the
metaphase plate had bright kinetochore fibers and little
(Fig. 4 
 
C
 
, 
 
red arrow
 
) or no (Fig. 4, 
 
B
 
 and 
 
D
 
, 
 
green arrow
 
)
Mad2 labeling. In addition to kinetochore labeling, Mad2
was sometimes seen associated with spindle poles (Fig. 4
 
B
 
,
 
 white arrowhead
 
) and kinetochore microtubules (Fig. 4
 
C
 
, 
 
white arrowhead
 
). By late metaphase, Mad2 was not de-
tectable on kinetochores (Fig. 4 
 
E
 
), and Mad2 was never
seen on anaphase kinetochores (Fig. 4 
 
F
 
).
 
PtK
 
1 Kinetochores at the Metaphase Plate Are
Under Tension
We have previously shown that kinetochores attached to
the spindle in mitotic newt lung cells are under tension
(Waters et al., 1996a). That is, the centromere chromatin is
stretched and the distance between sister kinetochores in-
Figure 2. Mad2 rebinds PtK1 kinetochores after microtubule de-
polymerization. This metaphase cell was treated with 20 mg/ml
nocodazole for 20 min at 378C before being fixed and processed
for immunofluorescence. Coverslips were scribed before drug
treatment to aid in subsequent identification of cells. Digital DIC
(black and white) and Mad2 (pink/red) images were pseudocol-
ored and overlaid. The majority of the 22 kinetochores are visible
in this optical section.
Figure 3. Mad2 leaves attached kinetochores.
(A–C) Micrograph of a late prometaphase PtK1
cell with one mono-oriented chromosome. This
cell was first lysed and extracted to rinse away
cytoplasmic Mad2, and then microtubules were
depolymerized. The cell was fixed and immuno-
labeled with CREST serum (B) and antibodies
to Mad2 (C). (A) DIC image. (B) An immuno-
fluorescence micrograph showing that kineto-
chores labeled normally with CREST serum af-
ter the treatment used to depolymerized microtubules after cell lysis. (C) An immunofluorescence micrograph showing Mad2
localization. Mad2 is found at the kinetochore that was unattached before treatment (bottom arrow), but is not present on previously at-
tached kinetochores (top arrow). This demonstrates that Mad2 is not simply masked by microtubules bound to the kinetochore, but is
lost after microtubule attachment. Bar, 5 mm.Waters et al. Kinetochore Mad2 1185
creases as microtubules interact with the kinetochores and
poleward pulling forces are generated. To determine if this
is also true for PtK1 cells, we fixed and processed cells for
immunofluorescent labeling of kinetochores using CREST
serum. We then collected Z-series optical sections of
prophase and late metaphase cells, and measured interki-
netochore distances as previously described (Waters et al.,
1996a). During prophase, the nuclear envelope inhibits
microtubules from interacting with kinetochores. There-
fore, there are no poleward forces acting on prophase ki-
netochores and the distance between sister kinetochores
on late prophase chromosomes can be considered the
“rest length” (Waters et al., 1996a). In contrast, sister ki-
netochores on bi-oriented chromosomes are subject to op-
posing net poleward forces that could produce tension at
the kinetochores and stretch the centromeric chromatin,
increasing the distance between kinetochores. We found
that the average interkinetochore distance in metaphase
PtK1 cells was 3.6 mm (range 5 2.4–4.7 mm; Fig. 5 E),
whereas the interkinetochore rest length was 1.4 mm
(range  5  1.2–1.7  mm; Fig. 5 A and B; Table I). In fact, the
interkinetochore distance was well above the range of the
Figure 4. Mad2 leaves kineto-
chores as they accumulate ki-
netochore microtubules. Mi-
totic PtK1 cells were labeled
with antibodies to Mad2 (or-
ange/pink), antibodies to a-tubu-
lin (green), and the DNA stain
Hoechst 33342 (blue). (A) Just
after nuclear envelope break-
down. White arrows, Mad2 ac-
cumulating on kinetochores;
white arrowhead, Mad2 on re-
sidual nuclear envelope. (B)
Early prometaphase. Green ar-
rowhead, kinetochore fibers
are visible as bright dense bun-
dles of green microtubules that
end abruptly on a chromo-
some;  white arrowhead, spindle
pole. (C) Mid-prometaphase.
White arrowhead, Mad2 on ki-
netochore microtubules. (D)
Late  prometaphase. (E) Meta-
phase. (F) Anaphase. Yellow
arrows, newly attached lead-
ing kinetochores on congress-
ing chromosomes label brightly
for Mad2; purple arrows, trail-
ing kinetochores on attached
kinetochores label less brightly;
green arrows, attached kineto-
chores that lack Mad2; and red
arrows, attached kinetochores
on which some Mad2 is still
visible.The Journal of Cell Biology, Volume 141, 1998 1186
rest length for each of the 40 chromosomes we examined
in 5 PtK1 metaphase cells (Fig. 5 E). Therefore, all kineto-
chores in PtK1 metaphase cells are under net tension.
Taxol Treatment Decreases Tension at Kinetochores
We have previously shown that treatment of metaphase
newt lung cells with 10 mM taxol for 45 min reduces cen-
tromere stretch to the rest length whereas kinetochores re-
tain their kinetochore fibers (Waters et al., 1996b). To de-
termine if taxol effects the amount of tension at the
kinetochores in PtK1 cells, we treated cells with 10 mM
taxol in media for 45 min at 378C. We then fixed the cells
and measured the distance between sister kinetochores in
metaphase cells (36 chromosomes in 6 cells) as described
above and in Waters et al. (1996a). We found that the av-
erage interkinetochore distance in taxol-treated metaphase
cells was only 1.7 mm (range 5 1.2–1.9 mm; Fig. 5, C–E;
Table I), close to the rest length of 1.4 mm (range 1.2–1.7
mm). In fact, for each of the chromosomes we examined in
taxol-treated cells, the interkinetochore distance was below
the range of the interkinetochore distances in metaphase
cells (Fig. 5 E). Therefore, treatment with taxol substan-
tially reduces tension at all kinetochores in PtK1 cells.
Taxol-treated Metaphase Cells Have Mad2 Bound to at 
Least One but Not All Kinetochores
To see if Mad2 localizes to kinetochores in taxol-treated
metaphase cells, we treated PtK1 cells with 10 mM taxol for
45 min at 378C, and then fixed and immunofluorescently
labeled the cells with antibodies to Mad2 and CREST se-
rum. We then collected Z-series 0.5-mm optical sections
(Waters et al., 1996b) of 35 metaphase cells. We identified
metaphase cells as cells with all chromosomes tightly
aligned at the spindle equator. By optically sectioning the
cells in the Z direction, we were able to visualize all of the
22 kinetochores in each PtK1 cell (Fig. 6). We found that in
metaphase cells treated with taxol for 45 min, Mad2 local-
ized to at least one and up to six kinetochores, with an av-
erage of 2.6 kinetochores labeled in each cell (Fig. 6, E–H;
Table II). Results for longer incubations in taxol were sim-
ilar to 45-min treatments; even after cells had been ar-
rested in taxol for 3 h, we found that Mad2 localized to at
least one but not all kinetochores in each cell we examined
(n 5 15; Fig. 6 K). In fact, we never found a taxol-treated
metaphase cell that did not have Mad2 on any kineto-
chores (Fig. 6 J). This result differs from untreated control
cells processed for immunofluorescence and examined in
the same manner. 42% of untreated metaphase cells did
not have Mad2 on any kinetochores (see Fig. 4 E), with an
average of 0.9 kinetochores labeled in each cell (range 5
0–5; Table II).
We also treated PtK1 cells with 10 mM taxol for 45 min
at 378C, and then fixed and immunofluorescently labeled
the cells for the phosphoepitope 3f3/2. Consistent with
previous reports by Gorbsky and Ricketts (1993), we
found that 3f3/2 was phosphorylated on all kinetochores in
the 8 taxol-treated metaphase cells we examined (Fig. 6,
A–D; Table II).
To maintain 3f3/2 phosphorylation during cell lysis, the
phosphatase inhibitor microcystin must be added to the ly-
sis buffer (Gorbsky and Ricketts, 1993). We do not use mi-
crocystin in our standard protocol for fixation of Mad2.
Therefore, the 3f3/2 epitope becomes dephosphorylated
during cell lysis when we process cells for Mad2 immuno-
fluorescence. We worried that Mad2 localization to kine-
tochores after taxol treatment may depend on the phos-
Figure 5. Tension at PtK1
metaphase cell kinetochores
is reduced after treatment
with 10 mM taxol. (A) A DIC
micrograph of a control
metaphase PtK1 cell. (B) A
fluorescence micrograph of
the same cell shown in A,
showing kinetochores la-
beled with CREST serum. A pair of sister kinetochores are labeled with ar-
rows. (C) A DIC micrograph of a metaphase PtK1 cell that was incubated
in 10 mM taxol for 45 min before fixation. (D) A fluorescence micrograph
of the same cell shown in C, showing kinetochores labeled with CREST se-
rum. A pair of sister kinetochores are labeled with arrows. The distance be-
tween sister kinetochores in taxol-treated metaphase cells is shorter than in
control cells. (E) A histogram depicting the distribution of distances be-
tween sister kinetochores in prophase, control metaphase, and taxol-
treated metaphase cells. Sister kinetochores in prophase cells are “resting”
(white). After sister kinetochores become properly attached to the spindle,
net poleward forces stretch the centromere and generate tension on kineto-
chores (black). Taxol relieves this tension, decreasing the distance between
sister kinetochores (gray). Stars over black bars indicate the distances mea-
sured between those sister kinetochore pairs in which Mad2 localized to
one or both of the sisters (see Fig. 6; average 5 1.7; n 5 10). Bar, 10 mm.
Table I. Interkinetochore Distances
Average 6 SD Range n 
mm chromosomes/cells
Control prophase 1.4 6 0.1 1.2–1.7 33/5
Control metaphase 3.6 6 0.5 2.4–4.7 40/5
Taxol-treated metaphase 1.7 6 0.2 1.2–1.9 36/6Waters et al. Kinetochore Mad2 1187
phorylation state of the kinetochore, so we lysed cells in
lysis buffer containing 100 nM microcystin and processed
them for immunolabeling of Mad2 or 3f3/2. The addition
of microcystin to the lysis buffer resulted in preservation of
3f3/2 phosphorylation at the kinetochore, but had no effect
on Mad2 localization in control or taxol-treated cells (data
not shown).
Mad2 Is Necessary for Maintenance of the
Taxol-induced Mitotic Arrest
To confirm that 10 mM taxol arrests PtK1 cells in mitosis,
we time-lapse recorded five taxol-treated metaphase cells.
Consistent with previous reports (DeBrabander et al.,
1986; Jordan et al., 1993; Rieder et al., 1994), we found that
each of the cells remained in mitosis (as was determined by
the presence of condensed chromosomes and a spindle,
and the absence of a nuclear envelope) for at least 6 h.
Li and Benezra (1996) have shown that electroporation
of antibodies to hsMad2 into tissue culture cells inhibits
the mitotic arrest normally induced by nocodazole. Gorb-
sky et al. (1998) has shown that microinjection of the anti-
Mad2 polyclonal antibodies described by Chen et al.
(1996) into prometaphase PtK1 cells also results in prema-
ture anaphase onset (i.e., anaphase occurred before all ki-
netochores were attached to the spindle and aligned at the
metaphase plate). To determine if our antibody had the
same effect, we microinjected 14 prometaphase cells with
Figure 6. A comparison of
3f3/2 phosphorylation and
Mad2 localization at kineto-
chores after taxol treatment.
(A–H) Metaphase PtK1 cells
treated with 10 mM taxol for
45 min before fixation. (A–D)
A cell that was immunola-
beled with CREST serum
(B) and antibodies to the
3F3/2 phosphoepitope (C).
(E-H) Cells that were immu-
nolabeled with CREST se-
rum (F) and antibodies to
Mad2 (G). DIC images are
shown in A and E, and digital
color overlays of CREST
(red) and Mad2 (H; green) or
3f3/2 (D; green) are shown.
After taxol treatment, the
3F3/2 epitope is phosphory-
lated on all metaphase kine-
tochores (C and D), while
Mad2 is found on some but
not all kinetochores (G and
H). (I) A histogram compar-
ing the number of kineto-
chores under tension with
3f3/2 phosphorylation and
Mad2 localization to kineto-
chores in untreated (white,
U) and taxol-treated (10 mM
for 45 min; black, T) metaphase cells. In untreated cells, all 22 kinetochores were under tension. Taxol treatment reduced tension at all
kinetochores. Consistent with this, 3f3/2 was not phosphorylated on any kinetochores in untreated metaphase cells, but became rephos-
phorylated after tension was reduced with taxol. If Mad2 also responds to differences in tension at kinetochores, we would expect Mad2
to localize to all kinetochores after tension is reduced at all kinetochores with taxol. However, Mad2 only localized to an average of 2.6
kinetochores per metaphase cell after taxol treatment. (J) A histogram comparing the percentages of untreated and taxol-treated (10
mM for 45 min) metaphase cells that have no Mad2 on any kinetochores and that have Mad2 on at least one kinetochore. 42% of un-
treated metaphase cells had no detectable Mad2 labeling on any kinetochores. Presumably, these cells were close to anaphase onset. In
the remaining 58%, Mad2 localized to at least one kinetochore. In contrast, Mad2 localized to at least one kinetochore in every taxol-
treated cell we examined. This not only explains the slight increase in average number of kinetochores labeled with Mad2 after taxol-
treatment, but it also demonstrates that there is a strong correlation between Mad2 localization to at least one kinetochore and the mi-
totic arrest. (K) A DIC (black and white) and Mad2 (red) overlay showing a metaphase PtK1 cell treated with 10 mM taxol for 3 h before
fixation. Even after 3 h in taxol, Mad2 still localizes to at least one kinetochore.
Table II. Mad2 Kinetochore Localization After Taxol 
Treatment
Kinetochores
undertension
Kinetochores labled
with Mad2
Kinetochores
labeled with 3f3/2
Control metaphase 100%*   4% 0%‡
(22 per cell) (0.9 per cell; n 5 33)
Taxol-treated metaphase 0%* 12% 100%
(2.6 per cell; n 5 35) (n 5 8‡)
*See Table I.
‡See also Gorbsky and Ricketts, 1993.The Journal of Cell Biology, Volume 141, 1998 1188
0.4 mg/ml affinity-purified polyclonal antibodies to Mad2.
Microinjections with antibodies to Mad2 consistently caused
premature anaphase onset (14 of 14 cells) in prometaphase
cells (data not shown). Cells entered anaphase, as was de-
termined by sister chromatid separation and movement
poleward, an average of 12 min after microinjection with
antibodies to Mad2 (range 5 7–15 min) at 328–348C. The
chromosomes in microinjected cells subsequently decon-
densed, the nuclear envelope reformed, and the cells at-
tempted or finished cytokinesis.
To determine if Mad2 is necessary to maintain the taxol-
induced mitotic arrest, we microinjected affinity-purified
antibodies to XMad2 into seven prometaphase (Fig. 7,
A–C) and seven metaphase (Fig. 7, D–F) PtK1 cells that
had been incubated in 10 mM taxol for at least 45 min. Mi-
croinjection of antibodies to Mad2 consistently resulted in
exit from mitosis (14 out of 14 cells; Fig. 7, A–F). Both
taxol-treated prometaphase (range 5 7–20 min) and
metaphase (range 5 11–13 min) cells exited mitosis an av-
erage of 12 min after microinjection at 328–348C. Taxol
stabilizes spindle microtubules, blocks the assembly and
disassembly of microtubules at the kinetochore, and pre-
vents the majority of anaphase A and B (Waters et al.,
1996b). Therefore, microinjection of antibodies to Mad2
into taxol-treated prometaphase or metaphase cells re-
sulted in little to no chromosome movement. However,
sister chromatid separation was still visible (see Fig. 7, B
and E) and was used to determine when a cell exited mito-
sis. In addition, chromosomes always decondensed and the
cells often began or completed cytokinesis (see Fig. 7, C
and F). These events were never seen to occur in nearby
taxol-arrested mitotic cells on the same coverslip (data not
shown) or in control microinjected cells (Fig. 7, G–I), dem-
onstrating that the cells injected with antibodies to Mad2
overcame the taxol-induced arrest and exited mitosis.
We performed several control microinjections. We mi-
croinjected three untreated prometaphase and three taxol-
arrested metaphase PtK1 cells with buffer that had flowed
through the Microcon filter during antibody concentra-
tion. We also microinjected three untreated prometaphase
(data not shown) and five taxol-arrested metaphase (Fig.
7, G–I) cells with antibodies to Mad2 that had been pre-
blocked with Mad2 antigen for 1 h at room temperature.
None of these control microinjections had any visible ef-
fect (i.e., untreated cells finished mitosis normally and
taxol-treated cells remained arrested in mitosis for at least
2 h). To be sure that room temperature incubation or dilu-
tion was not decreasing the reactivity of the antibody, we
mixed the same volume ratio of buffer without antigen to
antibody and then incubated for 1 h at room temperature.
Each of the three prometaphase cells we microinjected
with incubated antibody entered anaphase prematurely
(data not shown).
Microinjected Antibodies to XMad2 Localize to
All Kinetochores
To determine where the microinjected antibodies to
Figure 7. Microinjection of Mad2
antibodies overcomes taxol-induced
mitotic arrest. (A–I) Phase micro-
graphs of PtK1 cells treated with 10
mM taxol for at least 45 min before
microinjection. Time is shown in
h:min after microinjection. (A) A
taxol-treated prometaphase cell sec-
onds before microinjection with an-
tibodies to Mad2. (B) 14 min later,
sister chromatids have visibly sepa-
rated (arrows). (C) By 38 min, chro-
mosomes are decondensing and
cytokinesis has begun. (D) A taxol-
treated metaphase cell seconds be-
fore microinjection with antibodies
to Mad2. (E) 19 min later, sister
chromatids have visibly separated
(arrows). (F) By 43 min, chromo-
somes are decondensing and cytoki-
nesis has begun. (G) A taxol-treated
metaphase cell seconds before mi-
croinjection with antibodies to Mad2
that had been pre-blocked with an-
tigen. (H and I) Even after 3 h, the
cell is still arrested in mitosis.Waters et al. Kinetochore Mad2 1189
XMad2 localized, we filmed both control (data not shown)
and taxol-treated (Fig. 8 B) cells that were microinjected
with antibodies to XMad2 until premature anaphase onset
occurred (12–18 min after injection). We then quickly re-
moved the coverslip from the viewing chamber and pro-
cessed the cells for immunofluorescence. The cells were
labeled with an anti–rabbit secondary antibody (no addi-
tional primary antibody was used) to visualize the distribu-
tion of the microinjected Mad2 antibodies (Fig. 8 C). The
kinetochores were also labeled with CREST serum (Fig. 8
D). We collected 0.5-mm Z-series optical sections, which
allowed us to identify all of the kinetochores in each cell.
We found that, after 12–18 min, the microinjected Mad2
antibodies had accumulated on all kinetochores of each of
the control prometaphase and metaphase cells, (n 5 3; data
not shown) and taxol-treated metaphase cells (n 5 5; Fig.
8, C and D) that we examined. Antibodies against Mad2
added to Xenopus M-phase egg extracts also accumulate
on kinetochores (Chen, R.H., and A.W. Murray, unpub-
lished results).
The approximate intracellular concentration of Mad2
antibodies after microinjection is 20–40 mg/ml (5–10% the
concentration of antibodies in the injection needle),
whereas we generally use z4 mg/ml Mad2 antibodies for
immunofluorescence. Therefore, a possible explanation
for the above results is that at higher concentrations, Mad2
antibodies localize to attached kinetochores. We lysed and
fixed PtK1 cells, and processed them for immunofluores-
cence using z40 mg/ml Mad2 antibodies. We found that
whereas the background fluorescence in the cytoplasm in-
creased, Mad2 localized to unattached but not attached ki-
netochores (data not shown). It should be also noted that
whereas cells at 328–348C were injected with antibodies
and fixed only z12–18 min after microinjection, the cells
processed for immunofluorescence were treated with anti-
bodies for 45 min at 348C.
Discussion
Mad2 Loss from Kinetochores Correlates with 
Accumulation of Kinetochore Microtubules
We wanted to carefully document the relationship be-
tween Mad2 loss from kinetochores and kinetochore fiber
formation (Fig. 4). McEwen et al. (1997) used same cell
video light microscopy/serial sectioning EM to meticu-
lously count the numbers of microtubules bound to the ki-
netochore at different stages of chromosome attachment
to the mitotic PtK1 spindle. Their results show that during
congression to the spindle equator, the trailing kineto-
chore always has at least twice as many kinetochore micro-
tubules as the newly attached, leading sister kinetochore.
Our immunofluorescence images of kinetochore microtu-
bules in prometaphase cells are consistent with these re-
sults; we found that trailing kinetochores were usually
bound to a brighter, denser kinetochore fiber than their
leading sister kinetochore (Fig. 4 B). Images of cells la-
beled with antibodies to both Mad2 and tubulin show that
kinetochores with little or no Mad2 labeling are bound to
bright, dense kinetochore fibers, and vice versa. McEwen
and colleagues (1997) also found that some metaphase ki-
netochores have not acquired their full complement of mi-
crotubules. We found that 4% of kinetochores showed
Mad2 labeling in control metaphase cells (Table II). In ad-
dition, McEwen et al. (1997) reported that the average
number of kinetochore microtubules increases in anaphase,
and we found that Mad2 is never present on anaphase ki-
netochores in control cells (Fig. 4 F). These data suggest
that Mad2 localization to kinetochores decreases as the
number of microtubules bound to the kinetochore in-
creases.
Mad2 Does Not Accumulate at Attached Kinetochores 
After Loss of Tension
Chromatin is elastic (Nicklas, 1988; Alexander and Rieder,
1991; Houchmandzadeh et al., 1997). Therefore, a stretch
across the centromeric chromatin, measured as an increase
in the distance between bi-oriented sister kinetochores, in-
dicates that the kinetochores are under tension. In this re-
port we show metaphase kinetochores in PtK1 cells are under
tension, and that treatment with taxol relieves that tension.
Figure 8. Microinjected Mad2
antibodies localize to both at-
tached and unattached kineto-
chores. Phase images of a
prometaphase PtK1 cell treated
with 10 mM taxol for 45 min be-
fore microinjection. Time is
shown in h:min. (A) Seconds be-
fore microinjection with anti-
bodies to Mad2. (B) 16 min
later, sister chromatids have visi-
bly separated (arrows in A and
B). (C) Localization of microin-
jected antibodies to Mad2. (D)
Microinjected antibodies to Mad2
(green) colocalize with kineto-
chores labeled with CREST se-
rum (red).The Journal of Cell Biology, Volume 141, 1998 1190
We exploited the fact that taxol treatment reduces ten-
sion at kinetochores, without dramatically decreasing the
average number of kinetochores microtubules (McEwen
et al., 1997), to determine the structural cue recognized
when Mad2 selectively binds kinetochores. After taxol
treatment, none of the kinetochores are under tension
(Table II; Fig. 5 E). Therefore, if Mad2 binds to kineto-
chores that are not under tension, one would expect to see
Mad2 bound to all kinetochores after taxol treatment.
However, if Mad2 binds to kinetochores that lack microtu-
bules, one would expect to see little Mad2 bound to kine-
tochores after taxol treatment. Consistent with this logic,
3f3/2, which has been shown to become dephosphorylated
after tension is applied to kinetochores, becomes rephos-
phorylated on all kinetochores after tension is relieved by
taxol treatment (Figs. 6 D, and 8; Gorbsky and Ricketts,
1993). However, Mad2 only binds to a very small fraction
of kinetochores after tension at kinetochores is reduced
with taxol treatment (Fig. 6, I and J). These data demon-
strate that reduced tension at kinetochores is not sufficient
to induce Mad2 to bind to kinetochores.
Mad2 Localizes to at Least One Kinetochore in All 
Taxol-arrested Cells
Taylor and McKeon (1997) overexpressed the kineto-
chore-binding domain of the murine homologue of Bub1
in tissue culture cells. This peptide localized to kineto-
chores, and presumably inhibited endogenous Bub1 from
binding to kinetochores. These data strongly suggest that
Bub1 must interact with kinetochores to get normal acti-
vation of the spindle checkpoint. These experiments have
not yet been done for Mad2, but our findings predict a
similar result. We found that 42% of untreated metaphase
cells do not have Mad2 on any kinetochores (Fig. 6, I and
J). Presumably, these cells were close to anaphase onset at
the time of fixation. However, each of the taxol-treated
metaphase cells we examined had Mad2 on at least one ki-
netochore (Fig. 6, I and J). These data show that there is a
strong correlation between Mad2 localization to kineto-
chores and mitotic arrest.
Why does Mad2 bind to a few kinetochores after taxol
treatment? We offer two possible explanations. McEwen
et al. (1997) found that taxol increases the range of num-
bers of microtubules bound to the kinetochore without
dramatically changing the average number. This means
that whereas some kinetochores have more kinetochore
microtubules after taxol treatment, others have less.
Therefore, after taxol treatment, Mad2 may bind to those
kinetochores that have lost microtubules. Alternatively,
taxol may arrest only those cells that never acquired a
complete complement of microtubules and therefore have
Mad2 on at least one kinetochore.
Mad2 Is Necessary for Maintenance of the
Taxol-induced Cell Cycle Arrest
The drug taxol is routinely and effectively used to treat
breast, ovarian, lung, and other cancers. However, the mo-
lecular mechanisms by which taxol prevents cell prolifera-
tion are not understood. Jordan et al. (1993) proposed that
the taxol-induced mitotic arrest occurs concurrent with a
decrease in microtubule dynamics. We have previously
shown that, initially taxol preferentially inhibits kineto-
chore microtubule plus end assembly and disassembly
without affecting minus end dynamics (Waters et al.,
1996b). As the drug accumulates in the cell over time, dy-
namics at the minus end are also suppressed. It is only af-
ter dynamics at both kinetochore microtubule ends are
suppressed that tension at the kinetochore is relieved
(Waters et al., 1996b). Therefore, the taxol-induced de-
crease in tension at the kinetochore is likely to be a conse-
quence of the decrease in microtubule dynamics.
The stabilizing effect of taxol on microtubules probably
also leads to the increase in the range of numbers of mi-
crotubules bound to the kinetochore (McEwen et al.,
1997). Kinetochore microtubules in untreated PtK1 cells
turnover with a t1/2 < 5–7 min (Cassimeris et al., 1990; Zhai
et al., 1995). Under normal conditions of kinetochore mi-
crotubule turnover, lost kinetochore microtubules are re-
placed when the kinetochore captures a dynamic polar
microtubule. As the concentration of taxol in the cell in-
creases and the microtubules become stabilized, kineto-
chore microtubules that are lost are probably less likely to
be replaced. Therefore, we propose that taxol treatment
signals a mitotic arrest because (a) tension at the kineto-
chore is lost, causing 3f3/2 phosphorylation, and (b) micro-
tubules are lost or not acquired by some kinetochores,
causing Mad2 to accumulate at those kinetochores.
3f3/2 and Mad2
Consistent with data that 3f3/2 becomes dephosphorylated
when kinetochores are placed under tension (Nicklas et al.,
1995), our results show that 3f3/2 becomes rephosphory-
lated after tension is relieved with taxol (Figs. 5 and 7).
Microinjection of antibodies against 3f3/2 has been shown
to block dephosphorylation and result in a metaphase ar-
rest (Campbell and Gorbsky, 1995). This suggests that re-
moval of the 3f3/2 epitope is required to progress to
anaphase, or that binding of the 3f3/2 antibody sterically
inhibits some step required to promote anaphase. The ef-
fect of 3f3/2 antibody injection on Mad2 is not known;
Mad2 may localize to kinetochores when 3f3/2 dephosphor-
ylation is prevented by antibody injection. This would
place 3f3/2 phosphorylation upstream of Mad2 binding,
and the spindle checkpoint would thereby monitor both
tension and attachment in the same pathway.
Mad2 Binds Transiently to Attached Kinetochores
The accumulation of microinjected antibodies to Mad2 on
attached kinetochores (Fig. 8) is in striking contrast to ob-
servations that Mad2 is not found on the majority of at-
tached kinetochores when localized with standard immuno-
fluorescence (Fig. 4). This suggests that Mad2 interacts
transiently with attached kinetochores, and that microin-
jected antibodies prevent dissociation of Mad2 from kine-
tochores. Mad2 may transiently bind to attached kineto-
chores as microtubule-binding sites are exposed during
kinetochore microtubule turnover (Zhai et al., 1995). In
addition, because each antibody binds two Mad2 proteins,
antibody bound to one Mad2 at the kinetochore may re-
cruit another Mad2 from the cytoplasmic pool.
These results also show that Mad2 does not have to
physically leave the kinetochore for anaphase onset to oc-Waters et al. Kinetochore Mad2 1191
cur. Instead, our microinjected antibodies probably block
interaction of Mad2 with other molecules necessary for
signaling inhibition of anaphase, such as homologues of
Cdc20 (Hwang et al., 1998) or components of the Anaphase
Promoting Complex (He et al., 1997; Li et al., 1997).
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